[1] |
Rustad KC, Wong VW, Gurtner GC . The role of focal adhesion complexes in fibroblast mechanotransduction during scar formation[J]. Differentiation, 2013,86(3):87-91.
|
[2] |
Wang YJ, Zhang ZF, Fan SH , et al. MicroRNA-433 inhibits oral squamous cell carcinoma cells by targeting FAK[J]. Oncotarget, 2017,8(59):100227-100241.
|
[3] |
Otani H, Yamamoto H, Takaoka M , et al. TAE226, a bis-anilino pyrimidine compound, inhibits the EGFR-mutant kinase including T790M mutant to show anti-tumor effect on EGFR-mutant non-small cell lung cancer cells[J]. PLoS One, 2015,10(6):e0129838.
|
[4] |
Sathiyasekar AC, Chandrasekar P, Pakash A , et al. Overview of immunology of oral squamous cell carcinoma[J]. J Pharm Bioallied Sci, 2016,8(Suppl 1):S8-S12.
|
[5] |
Çankaya H, Güneri P, Epstein JB . Adjunctive methods and devices for clinical detection of oral squamous cell carcinoma[J]. Oral Health Prev Dent, 2015,13(1):29-39.
|
[6] |
Zhang MX, Zheng SS, Jing CY , et al. S100A11 promotes TGF-β1-induced epithelial-mesenchymal transition through SMAD2/3 signaling pathway in intrahepatic cholangiocarcinoma[J]. Future Oncol, 2018,14(9):837-847.
|
[7] |
Lamouille S, Xu J, Derynck R . Molecular mechanisms of epithelial-mesenchymal transition[J]. Nat Rev Mol Cell Biol, 2014,15(3):178-196.
|
[8] |
Goñi GM, Epifano C, Boskovic J , et al. Phosphatidylinositol 4,5-bisphosphate triggers activation of focal adhesion kinase by inducing clustering and conformational changes[J]. Proc Natl Acad Sci USA, 2014,111(31):E3177-E3186.
|
[9] |
Lietha D, Eck MJ . Crystal structures of the FAK kinase in complex with TAE226 and related bis-anilino pyrimidine inhibitors reveal a helical DFG conformation[J]. PLoS One, 2008,3(11):e3800.
|
[10] |
Hehlgans S, Lange I, Eke I , et al. 3D cell cultures of human head and neck squamous cell carcinoma cells are radiosensitized by the focal adhesion kinase inhibitor TAE226[J]. Radiother Oncol, 2009,92(3):371-378.
|
[11] |
Kurio N, Shimo T, Fukazawa T , et al. Anti-tumor effect in human breast cancer by TAE226, a dual inhibitor for FAK and IGF-IR in vitro and in vivo[J]. Exp Cell Res, 2011,317(8):1134-1146.
|
[12] |
Attramadal CG, Kumar S, Boysen ME , et al. Tumor budding, EMT and cancer stem cells in T1-2/N0 oral squamous cell carcinomas[J]. Anticancer Res, 2015,35(11):6111-6120.
|
[13] |
Natsuizaka M, Whelan KA, Kagawa S , et al. Interplay between Notch1 and Notch3 promotes EMT and tumor initiation in squamous cell carcinoma[J]. Nat Commun, 2017,8(1):1758.
|
[14] |
Palen K, Weber J, Dwinell MB , et al. E-cadherin re-expression shows in vivo evidence for mesenchymal to epithelial transition in clonal metastatic breast tumor cells[J]. Oncotarget, 2016,7(28):43363-43375.
|
[15] |
Hermiston ML, Wong MH, Gordon JI . Forced expression of E-cadherin in the mouse intestinal epithelium slows cell migration and provides evidence for nonautonomous regulation of cell fate in a self-renewing system.[J]. Genes Dev, 1996,10(8):985-996.
|
[16] |
Perl AK, Wilgenbus P, Dahl U , et al. A causal role for E-cadherin in the transition from adenoma to carcinoma[J]. Nature, 1998,392(6672):190-193.
|
[17] |
Zhou WH, Gong L, Wu QC , et al. Correction to: PHF8 upregulation contributes to autophagic degradation of E-cadherin, epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma[J]. J Exp Clin Cancer Res, 2018. doi. 10.1186/s13046-018-0944-7.
|
[18] |
Murakami M, Imabayashi K, Watanabe A , et al. Identification of novel function of vimentin for quality standard for regenerated pulp tissue[J]. J Endod, 2012,38(7):920-926.
|
[19] |
Li LF, Wei ZJ, Sun H , et al. Abnormal β-catenin immunohistochemical expression as a prognostic factor in gastric cancer: a meta-analysis[J]. World J Gastroenterol, 2014,20(34):12313-12321.
|
[20] |
Schultze A, Decker S, Otten J , et al. TAE226-mediated inhibition of focal adhesion kinase interferes with tumor angiogenesis and vasculogenesis[J]. Invest New Drugs, 2010,28(6):825-833.
|
[21] |
Kurio N, Shimo T, Fukazawa T , et al. Anti-tumor effect of a novel FAK inhibitor TAE226 against human oral squamous cell carcinoma[J]. Oral Oncol, 2012,48(11):1159-1170.
|
[22] |
Jones RJ, Brunton VG, Frame MC . Adhesion-linked kinases in cancer, emphasis on Src, focal adhesion kinase and PI 3-kinase[J]. Eur J Cancer, 2000,36(13):1595-1606.
|